文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

生物标志物指导的疑似脓毒症住院患者抗生素疗程:ADAPT-Sepsis随机临床试验

Biomarker-Guided Antibiotic Duration for Hospitalized Patients With Suspected Sepsis: The ADAPT-Sepsis Randomized Clinical Trial.
PubMed 文献 · JAMA · 2025-01-01
一句话结论在疑似脓毒症的危重成人中,每日降钙素原(PCT)指导的决策安全缩短抗生素疗程,而C反应蛋白(CRP)指导的决策未能缩短疗程,且死亡率结论不确定。

ADAPT-Sepsis是一项在41个英国国家医疗服务体系(NHS)重症监护病房开展的多中心、干预隐藏随机临床试验,纳入2760例疑似脓毒症、启动静脉抗生素后24小时内需重症监护且可能继续抗生素至少72小时的成人。患者随机分为每日PCT指导组(918例)、每日CRP指导组(924例)和标准治疗组(918例)。主要终点为28天内抗生素总疗程(有效性)和全因死亡率(安全性)。PCT指导组较标准治疗组抗生素疗程显著缩短(平均差异0.88天,95%CI 0.19-1.58,P=0.01),28天全因死亡率非劣效(非劣效界值5.4%,绝对差异1.57,95%CI -2.18至5.32,P=0.02)。CRP指导组与标准治疗组抗生素疗程无差异(平均差异0.09天,95%CI -0.60至0.79,P=0.79),死亡率结论不确定(绝对差异1.69,95%CI -2.07至5.45,P=0.03)。

要点

  • 在疑似脓毒症的危重成人中,每日PCT指导的抗生素决策较标准治疗缩短28天内抗生素疗程(平均9.8天 vs 10.7天,平均差异0.88天,95%CI 0.19-1.58,P=0.01)。
  • PCT指导组28天全因死亡率非劣效于标准治疗(20.9% vs 19.4%,绝对差异1.57,95%CI -2.18至5.32,P=0.02;非劣效界值5.4%)。
  • CRP指导组与标准治疗组抗生素疗程无差异(平均10.6天 vs 10.7天,平均差异0.09天,95%CI -0.60至0.79,P=0.79)。
  • CRP指导组28天全因死亡率与标准治疗比较结论不确定(21.1% vs 19.4%,绝对差异1.69,95%CI -2.07至5.45,P=0.03)。

适用人群与场景

  • 年龄≥18岁的成人,疑似脓毒症,启动静脉抗生素后24小时内需重症监护,且可能继续抗生素至少72小时。
  • 来自41个英国国家医疗服务体系(NHS)重症监护病房。

处置流程与药物剂量

  • 每日PCT指导方案:根据每日PCT测量结果决策抗生素疗程,较标准治疗缩短28天内抗生素疗程(平均9.8天 vs 10.7天,平均差异0.88天,95%CI 0.19-1.58,P=0.01)。
  • 每日CRP指导方案:根据每日CRP测量结果决策抗生素疗程,与标准治疗相比抗生素疗程无差异(平均10.6天 vs 10.7天,平均差异0.09天,95%CI -0.60至0.79,P=0.79)。

研究设计与关键结果

  • 多中心、干预隐藏随机临床试验,纳入2760例成人(平均年龄60.2岁,SD 15.4;60.3%男性),随机分为每日PCT指导组(918例)、每日CRP指导组(924例)和标准治疗组(918例)。
  • 主要终点:28天内抗生素总疗程,PCT指导组平均9.8天(SD 7.2)vs 标准治疗组平均10.7天(SD 7.6),平均差异0.88天(95%CI 0.19-1.58,P=0.01)。
  • 主要终点:28天全因死亡率,PCT指导组20.9%(184/879)vs 标准治疗组19.4%(170/878),绝对差异1.57(95%CI -2.18至5.32,P=0.02),非劣效界值5.4%。
  • CRP指导组28天内抗生素疗程平均10.6天(SD 7.7)vs 标准治疗组10.7天,平均差异0.09天(95%CI -0.60至0.79,P=0.79)。
  • CRP指导组28天全因死亡率21.1%(184/874)vs 标准治疗组19.4%,绝对差异1.69(95%CI -2.07至5.45,P=0.03),结论不确定。

证据类型、等级与局限

  • 证据类型:多中心、干预隐藏随机临床试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,与标准治疗相比,PCT指导的决策可安全缩短抗生素疗程,而CRP指导的决策不能缩短抗生素疗程,且CRP指导的全因死亡率结论不确定。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: For hospitalized critically ill adults with suspected sepsis, procalcitonin (PCT) and C-reactive protein (CRP) monitoring protocols can guide the duration of antibiotic therapy, but the evidence of the effect and safety of these protocols remains uncertain.

OBJECTIVE: To determine whether decisions based on assessment of CRP or PCT safely results in a reduction in the duration of antibiotic therapy.

DESIGN, SETTING, AND PARTICIPANTS: A multicenter, intervention-concealed randomized clinical trial, involving 2760 adults (≥18 years), in 41 UK National Health Service (NHS) intensive care units, requiring critical care within 24 hours of initiating intravenous antibiotics for suspected sepsis and likely to continue antibiotics for at least 72 hours.

INTERVENTION: From January 1, 2018, to June 5, 2024, 918 patients were assigned to the daily PCT-guided protocol, 924 to the daily CRP-guided protocol, and 918 assigned to standard care.

MAIN OUTCOMES AND MEASURES: The primary outcomes were total duration of antibiotics (effectiveness) and all-cause mortality (safety) to 28 days. Secondary outcomes included critical care unit data and hospital stay data. Ninety-day all-cause mortality was also collected.

RESULTS: Among the randomized patients (mean age 60.2 [SD, 15.4] years; 60.3% males), there was a significant reduction in antibiotic duration from randomization to 28 days for those in the daily PCT-guided protocol compared with standard care (mean duration, 10.7 [SD, 7.6] days for standard care and 9.8 [SD, 7.2] days for PCT; mean difference, 0.88 days; 95% CI, 0.19 to 1.58, P = .01). For all-cause mortality up to 28 days, the daily PCT-guided protocol was noninferior to standard care, where the noninferiority margin was set at 5.4% (19.4% [170 of 878] of patients receiving standard care; 20.9% [184 of 879], PCT; absolute difference, 1.57; 95% CI, -2.18 to 5.32; P = .02). No difference was found in antibiotic duration for standard care vs daily CRP-guided protocol (mean duration, 10.6 [7.7] days for CRP; mean difference, 0.09; 95% CI, -0.60 to 0.79; P = .79). For all-cause mortality, the daily CRP-guided protocol was inconclusive compared with standard care (21.1% [184 of 874] for CRP; absolute difference, 1.69; 95% CI, -2.07 to 5.45; P = .03).

CONCLUSIONS AND RELEVANCE: Care guided by measurement of PCT reduces antibiotic duration safely compared with standard care, but CRP does not. All-cause mortality for CRP was inconclusive.

TRIAL REGISTRATION: isrctn.org Identifier: ISRCTN47473244.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Dark P, Hossain A, McAuley DF, et al. Biomarker-Guided Antibiotic Duration for Hospitalized Patients With Suspected Sepsis: The ADAPT-Sepsis Randomized Clinical Trial. JAMA. 2025. PMID: 39652885. doi:10.1001/jama.2024.26458

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。